CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics (OTCBB: NVIV), a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that Frank Reynolds, CEO of InVivo, will address the 5th Annual Working 2 Walk Science & Advocacy Symposium taking place November 11 – 13, 2010 in Phoenix, Arizona. Mr. Reynolds’ remarks, titled “Changing the Face of Neuroscience: Are Stem Cells Really Required to Heal a Spinal Cord Injury?” will be given at 9:10am ET on Friday, November 12.
